A detailed history of Fortis Group Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Fortis Group Advisors, LLC holds 380 shares of VTRS stock, worth $4,609. This represents 0.0% of its overall portfolio holdings.

Number of Shares
380
Previous 380 -0.0%
Holding current value
$4,609
Previous $4.54 Million 10.97%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$11.27 - $13.53 $4,282 - $5,141
-380 Reduced 50.0%
380 $4.54 Million
Q4 2023

Mar 04, 2024

BUY
$8.77 - $10.85 $3,332 - $4,123
380 Added 100.0%
760 $8.23 Million
Q3 2023

Dec 01, 2023

BUY
$9.59 - $11.35 $3,644 - $4,313
380 New
380 $3.75 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.7B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Fortis Group Advisors, LLC Portfolio

Follow Fortis Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Group Advisors, LLC with notifications on news.